AKT1 and Insulin resistance: Experimental work should explore how TyG-related insulin resistance promotes colorectal tumorigenesis through insulin/IGF-1 signaling, PI3K–AKT–mTOR activation, chronic inflammation, and microbiome or bile acid alterations.